Gene Logic
Founded Year
1994Stage
IPO | IPOTotal Raised
$30.1MDate of IPO
11/21/1997About Gene Logic
Producer of functional genomic database whose product, Gene Express, contains gene expression profiles of normal and diseased cells. The company plans to provide its collaborators in the pharmaceutical and diagnostic industries with molecular bioinformatic databases and services that will enable the rapid discovery of genomic targets for new drug and diagnostic development. Applications for the company's products include diagnostics to determine an individuals risk for a specified disease and reversing the genetic process underlying the development of degenerative diseases. Gene Logic plans to establish gene discovery collaboration with pharmaceutical and diagnostic companies in the areas of osteoporosis, cancer, cardiovascular and CNS diseases.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Latest Gene Logic News
Nov 25, 2016
Advertisement Topics Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 06:42 EST 25 Nov 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Formerly Gene Logic, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc. since January 2007. Key Findings Provides intelligence on Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Ore Pharmaceuticals Inc. Formerly Gene Logic, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
Gene Logic Frequently Asked Questions (FAQ)
When was Gene Logic founded?
Gene Logic was founded in 1994.
Where is Gene Logic's headquarters?
Gene Logic's headquarters is located at 10150 Old Columbia Road, Columbia.
What is Gene Logic's latest funding round?
Gene Logic's latest funding round is IPO.
How much did Gene Logic raise?
Gene Logic raised a total of $30.1M.
Who are the investors of Gene Logic?
Investors of Gene Logic include Forward Ventures, Granite Ventures, Biotechvest, Weiss, Peck & Greer Ventu, Oxford Bioscience Partners and 6 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
